APM
CVAC

Avidity Partners Management’s CureVac CVAC Stock Holding History

Avidity Partners Management’s Portfolio CVAC Stock Details CVAC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-3,116,100
Closed -$21.3M – 79
2023
Q3 		$21.3M Sell
3,116,100
-1,183,900
-28% -$10.5M 0.86% 46
2023
Q2 		$44.8M Buy
4,300,000
+750,000
+21% +$6.71M 1.56% 22
2023
Q1 		$24.7M Buy
+3,550,000
New +$30.9M 0.82% 41

Other funds holding CVAC

RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $38.9B AUM 28.51% 1-Year Est. Return
GF
Gates Foundation Seattle, Washington $43.5M AUM 14.19% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
Walleye Capital
Walleye Capital New York $28B AUM 44.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Avidity Partners Management's CVAC Position: Q4 2023 in Review

Avidity Partners Management sold out of CureVac (CVAC) in Q4 2023, closing a stake of 3,116,100 shares — an estimated $21.3M sold.

Avidity Partners Management first reported a position in CVAC in Q1 2023 and held it in 3 quarters. The position peaked at $44.8M in Q2 2023. 90 funds tracked by Wall St. Rank hold CVAC as of Q4 2023.

  • Avidity Partners Management reported no remaining CureVac position as of Q4 2023 after selling out during the quarter.
  • Avidity Partners Management sold 3,116,100 CureVac shares in Q4 2023, an estimated $21.3M.
  • Avidity Partners Management first reported a position in CureVac in Q1 2023 and held it in 3 quarters.
  • Avidity Partners Management's CureVac position peaked at $44.8M in Q2 2023.
  • 90 funds tracked by Wall St. Rank held CureVac as of Q4 2023.

Based on Avidity Partners Management's 13F filing for Q4 2023, filed 14 Feb 2024.